Medical Review Process

SemaLiving covers GLP-1 medications in a YMYL category. Our standard is to keep patient safety, source quality, and clinician oversight ahead of affiliate conversion.

Current reviewer status

Publish gate: SemaLiving still needs a named licensed clinician reviewer on the masthead before pages should claim “medically reviewed.” Until then, content should be labeled educational/editorial and routed through human review before traffic launch.

Reviewer page template

When Matt/team selects the clinician reviewer, use the Medical Reviewer / Author Page Template to collect bio fields, credentials, reviewer badge copy, and schema inputs before publishing reviewer claims.

Review workflow

• Start with FDA labels, manufacturer safety information, PubMed/clinical literature, CDC/NIH sources where relevant, and current provider terms.
• Separate patient education from diagnosis, prescribing, or individualized treatment advice.
• Flag side effects with “what is common” and “when to call your doctor” guidance.
• Add published, updated, and last-reviewed dates to articles as they go live.
• Re-review pages after medication label changes, major provider pricing changes, or every 6–12 months.